Targeting protein acetylation for improving cancer therapy

Area of Science:

• Biochemistry
• Molecular Biology
• Cell Biology

Background:

• Protein acetylation is a crucial post-translational modification affecting protein structure, function, and localization.
• Histone acetyltransferases (HAT) and histone deacetylases (HDAC) regulate cellular homeostasis and damage responses like DNA repair and apoptosis.
• Elevated histone deacetylase levels in tumors highlight their role as anticancer drug targets.

Purpose of the Study:

• To explore the role of protein acetylation in cellular functions under various stress conditions.
• To investigate the newly discovered calreticulin-mediated protein acetylation pathway.
• To understand the interplay between HAT/HDAC and calreticulin acetylation for drug design.

Main Methods:

• Review of existing literature on protein acetylation.
• Analysis of the mechanisms of HAT/HDAC and calreticulin in protein acetylation.
• Discussion of cellular responses to stress in relation to acetylation pathways.

Main Results:

• Protein acetylation is vital for signal transduction and cellular functions under both normal and stress conditions.
• Calreticulin efficiently acetylates proteins using polyphenolic acetates, extending acetylation beyond the HAT/HDAC system.
• Histone deacetylase inhibition impacts nuclear events and proliferation, with elevated levels in many cancers.

Conclusions:

• Understanding calreticulin-mediated acetylation alongside HAT/HDAC pathways is key to developing novel cancer therapeutics.
• Targeting protein acetylation offers a promising strategy for anticancer drug development.
• Further research into acetylation mechanisms under stress conditions is warranted for therapeutic advancements.